Literature DB >> 7595077

Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of p-glycoprotein.

F J Field1, E Born, H Chen, S Murthy, S N Mathur.   

Abstract

Acylcoenzyme A:cholesterol acyltransferase (ACAT) and/or cholesteryl esters have been implicated as important factors in the normal assembly of apolipoprotein (apoB)-containing lipoproteins. The predominant substrate for ACAT is believed to originate from cholesterol contained within the plasma membrane. To investigate a possible role of intestinal plasma membrane cholesterol in triacylglycerol-rich lipoprotein synthesis and secretion, CaCo-2 cells were incubated with agents that are known to interfere with cholesterol transport from the plasma membrane to the ER. Progesterone, verapamil, and trifluoperazine significantly decreased the movement of cholesterol from plasma membrane to endoplasmic reticulum (ER) in CaCo-2 cells. Without altering the synthesis of apoB and independent of their effects on cellular cholesterol esterification, progesterone, verapamil, and trifluoperazine decreased the basolateral secretion of triacylglycerols, cholesteryl esters, and immunoreactive and newly synthesized apoB. The three agents also interfered with the esterification of cholesterol absorbed from taurocholate micelles. As progesterone, verapamil, and trifluoperazine are recognized inhibitors of p-glycoprotein, a variety of agents that have been shown to interfere with p-glycoprotein function were tested to investigate their effects on cholesterol transport and apoB secretion. All the agents significantly decreased in parallel both cholesterol transport and apoB secretion. In contrast, methotrexate, an antimetabolite that does not interact with p-glycoprotein, had no effect. Nigericin, a potassium ionophore, which causes alkalinization of intracellular vesicles, also caused a profound inhibition of cholesterol transport and apoB secretion. Preventing plasma membrane cholesterol from arriving at the ER, or inhibiting the esterification of plasma membrane cholesterol, does not alter apoB secretion. However, the results suggest a possible role for p-glycoprotein in normal cholesterol trafficking and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells. It is postulated that p-glycoprotein might function to maintain the acidic environment of transport vesicles, and therefore, could play a role in the transport of lipids by the intestine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595077

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells.

Authors:  Fergal Seeballuck; Marianne B Ashford; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

2.  Adaptation of enterocytic Caco-2 cells to glucose modulates triacylglycerol-rich lipoprotein secretion through triacylglycerol targeting into the endoplasmic reticulum lumen.

Authors:  Thomas Pauquai; Julien Bouchoux; Danielle Chateau; Romain Vidal; Monique Rousset; Jean Chambaz; Sylvie Demignot
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

Review 3.  Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.

Authors:  L G Baggetto
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

4.  Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies.

Authors:  Emma Lawless; Brendan T Griffin; Aoife O'Mahony; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-11-27       Impact factor: 4.200

5.  Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines.

Authors:  B Batetta; A Pani; M Putzolu; F Sanna; R Bonatesta; S Piras; O Spano; M F Mulas; S Dessí
Journal:  Cell Prolif       Date:  1999-02       Impact factor: 6.831

6.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

7.  Evaluation of the contribution of the ATP binding cassette transporter, P-glycoprotein, to in vivo cholesterol homeostasis.

Authors:  Stephen D Lee; Sheila J Thornton; Kristina Sachs-Barrable; Jenny H Kim; Kishor M Wasan
Journal:  Mol Pharm       Date:  2013-06-24       Impact factor: 4.939

8.  Dose-dependent targeted suppression of P-glycoprotein expression and function in Caco-2 cells.

Authors:  Stephen D Lee; Jo-Ann Osei-Twum; Kishor M Wasan
Journal:  Mol Pharm       Date:  2013-05-02       Impact factor: 4.939

Review 9.  Lipid rafts: dream or reality for cholesterol transporters?

Authors:  Stéphane Orlowski; Christine Coméra; François Tercé; Xavier Collet
Journal:  Eur Biophys J       Date:  2007-06-19       Impact factor: 2.095

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.